Rewiring Glycolysis in Cancer: From Tumor Initiation to Therapeutic Vulnerabilities
Cells · 2026
DOI: 10.3390/cells15090771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Shicai Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Changchun University of Chinese Medicine, Changchun 130117, China. Hauptthemen laut MEDLINE: Glycolysis, Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, Korea Government.
Abstract (Originalsprache)
Glycolysis is a defining feature of cancer metabolism, originally described by the Warburg effect. Increasing evidence indicates that cancer-associated glycolysis is not uniformly upregulated but dynamically rewired in response to oncogenic signaling, cellular demands, and microenvironmental cues. However, a framework integrating its temporal evolution and functional roles across tumorigenesis remains limited. In particular, how glycolytic rewiring drives malignant transformation, adapts during tumor progression, and generates context-dependent vulnerabilities has not been systematically synthesized. In this review, we examine glycolysis as a dynamic metabolic network evolving throughout tumor development. We discuss how early glycolytic rewiring, driven by oncogenic signaling and metabolic–epigenetic coupling, supports cell fate transitions and establishes redox and biosynthetic capacity during tumorigenesis. We then outline how glycolysis is remodeled during tumor progression through coordinated transcriptional, epigenetic, and post-translational regulation, as well as microenvironmental interactions and metabolic heterogeneity. Furthermore, we highlight glycolysis as an integrative hub linking immune evasion, cell death regulation, and metabolic plasticity, and discuss how glycolytic rewiring creates context-dependent metabolic dependencies that may be therapeutically exploited, along with emerging technologies that enable high-resolution characterization of tumor metabolism. Together, this review provides a conceptual framework for understanding glycolytic rewiring in cancer and outlines potential avenues for targeting metabolic vulnerabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Changchun University of Chinese Medicine, Changchun 130117, China.
- Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
ORCID-Profile: Seung-Jun Jeong, Yan Zhang, Dongryeol Ryu
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Korea Government
Zitieren
APA
Sun, S., Jia, L., Yu, Y., Jeong, S. J., Zhang, Y., Ryu, D., & Ta, G. (2026). Rewiring Glycolysis in Cancer: From Tumor Initiation to Therapeutic Vulnerabilities. Cells. https://doi.org/10.3390/cells15090771
Vancouver
Sun S, Jia L, Yu Y, Jeong SJ, Zhang Y, Ryu D, et al. Rewiring Glycolysis in Cancer: From Tumor Initiation to Therapeutic Vulnerabilities. Cells. 2026. doi:10.3390/cells15090771
BibTeX
@article{Sun2026,
author = {Sun, Shicai and Jia, Lulu and Yu, Ying and Jeong, Seung-Jun and Zhang, Yan and Ryu, Dongryeol and Ta, Guang},
title = {Rewiring Glycolysis in Cancer: From Tumor Initiation to Therapeutic Vulnerabilities},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15090771}
}
EUVIMED